Table 1 Characteristics of studies (n = 13).

Author year	Age (years)	Male (%)	AMI	N	Mortality (%)	PNI cut-off values^#	Outcomes	Follow-up period†	Country	NOS
Balaban Koçaş 2022	59.6	77.9	ACS‡	880	7.8	NA	Mortality/MACEs	12 m	Turkey	5
Basta 2016	65.7	75	STEMI	945	5.9	NA	Mortality	24 m	Italy	7
Chen 2017	58.3	80.9	STEMI	309	4.8	45	Mortality	19.5 m	China	9
Chen 2022	66.3	72.3	ACS‡	799	5.8	NA	Mortality	6 m	China	9
Cheng 2019	64.6	76.3	ACS‡	598	12.2	45	Mortality	14.8 m	China	8
Fan 2022	NA	75	ACS‡	1542	3.6	48.15	MACEs	38.1 m	China	8
Kalyoncuoglu 2021	68.5	71.5	NSTEMI	253	10.3	NA	MACCEs	20.5 m	Turkey	7
Kang 2022	63	67.9	ACS‡	1930	3.8	35 vs. 38	Mortality/MACEs	67.2 m	Korea	8
Karaaslan 2021	73	60	NSTEMI	376	7.4	46	Mortality	11.2 m	Turkey	8
Keskin 2017	58	81	STEMI	1823	4.9	44	Mortality	32.9 m	Turkey	9
Kim 2021	65.6	72.5	STEMI	1147	7.5	50 vs. 56	Mortality	12 m	Korea	9
Raposeiras Roubin 2020	66.2	74.5	ACS‡	5062	16.4	35 vs. 38	Mortality/MACEs	43.2 m	Spain	8
Yildirim 2021	73.1	51.6	NSTEMI	915	19.6	NA	Mortality	64.5 m	Turkey	8

m months, NA not available, ACS acute coronary syndrome, STEMI ST-segment elevation myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction.
^†Mean or median; MACEs major adverse cardiovascular events, MACCEs major adverse cardiac and cerebrovascular events, AMI acute myocardial infarction.
^‡Patients with ST-elevation myocardial infarction, non-ST elevation myocardial infarction, or unstable angina.
^#PNI cut-off values for mortality risk.

Quick links

Search